ACCO Brands Corporation
NYSE:ACCOBusiness Equipment & Supplies
+$0.05 today
- Market cap
- $517.11M
- Beta
- 1.21
- P/E (TTM)
- 4.9
- EPS (TTM)
- $0.80
- Dividend yield
- 7.70%
Volume 1.77M
Average 1.07M
ACCO Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
ACCO Brands CorporationNYSE: ACCO
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables turns negative
Q1 FY2026 accounts payables was -$12.4M, compared with $1.8M a year earlier. Trailing-twelve-month accounts payables was -$4.2M.
Context
- Accounts payables amounted to 0.7% of revenue in FY2025, up 0.3 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near -$12.4M or moves back toward the trailing-twelve-month quarterly average of -$1.05M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 10M USD
- Year-over-year change
- +258.7%
- 4-year CAGR
- -47.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10M | +258.7% |
| FY2024 | 2024-12-31 | (6.3M) | +90.7% |
| FY2023 | 2023-12-31 | (68M) | -3.0% |
| FY2022 | 2022-12-31 | (66M) | -150.3% |
| FY2021 | 2021-12-31 | 131.2M | — |
Accounts Payables vs competitors
How ACCO compares with its peers on the latest reported figures
- ACCO's LTM Mar 2026 accounts payables of $4.2M is the 5th largest of the 11 companies compared; the peer median is $2.18M.
- Its year-over-year change of -151.2% is the 9th highest of 10, against a peer median of +126.8%.
- Accounts payables amounts to 0.3% of revenue for ACCO, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $64.2M | — | — | 4.4% | |
| LTM Mar 2026 | $9.2M | +126.8% | -18.7% | 0.4% | |
| LTM Mar 2026 | $6.63M | +1861.2% | — | 10.4% | |
| LTM Mar 2026 | $6.51M | +219.4% | -41.6% | 1.2% | |
| LTM Mar 2026 | $4.2M | -151.2% | — | 0.3% | |
| LTM Apr 2026 | $3.04M | -179.2% | -20.6% | 0.7% | |
| LTM Mar 2026 | $2.33M | +10.1% | +157.0% | 0.6% | |
| LTM Mar 2026 | $2.04M | +138.4% | — | 0.5% | |
| LTM Mar 2026 | $1.6M | -115.0% | — | 0.1% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $1.36M | -74.3% | +149.1% | 0.8% |
| LTM Feb 2026 | $1.12M | +227.3% | -30.4% | 0.3% | |
| Peer median (excluding ACCO) | $2.18M | +126.8% | -19.6% | 0.7% | |
Competitors are the stored peer set for ACCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 101.9M | (13.2M) | (21.8M) | (101.6M) | 41.3M |
| Depreciation & Amortization | 85.7M | 79.4M | 76.1M | 73.1M | 72.8M |
| Deferred Income Tax | (21M) | 1.3M | (20.1M) | (6.9M) | (3.5M) |
| Stock-Based Compensation | 15.2M | 9.5M | 14.8M | 11.9M | 11.5M |
| Change in Working Capital | (50.8M) | (79M) | (12.5M) | 4.5M | (48.9M) |
| Accounts Receivables | (77.6M) | 31.6M | (38.6M) | 43.3M | 5.2M |
| Inventory | (131.8M) | 23.2M | 85.5M | 38.3M | 1.1M |
| Accounts Payables | 131.2M | (66M) | (68M) | (6.3M) | 10M |
| Other Working Capital | 27.4M | (67.8M) | 8.6M | (70.8M) | (65.2M) |
| Other Non-Cash Items | 28.6M | 79.6M | 92.2M | 167.2M | (4.5M) |
| Operating Cash Flow | 159.6M | 77.6M | 128.7M | 148.2M | 68.7M |
| Capital Expenditures | (21.2M) | (16.5M) | (13.8M) | (15.9M) | (17.9M) |
| Acquisitions (Net) | 15.4M | 7.2M | 0 | 0 | (10.1M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 2.6M | 3.6M | 18.7M |
| Investing Cash Flow | (5.8M) | (9.3M) | (11.2M) | (12.3M) | (9.3M) |
| Debt Repayment | (102.9M) | 16.9M | (87.5M) | (74.7M) | (33.7M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (19.4M) | (1.7M) | (15M) | (15.1M) |
| Dividends Paid | (25.8M) | (28.6M) | (28.5M) | (28.4M) | (27M) |
| Other Financing Activities | (18.5M) | (14.7M) | 0 | (4.5M) | (900K) |
| Financing Cash Flow | (147.2M) | (48.3M) | (117.7M) | (122.6M) | (76.7M) |
| Effect of Forex Changes | (2M) | 1M | 4.4M | (5.6M) | 7.6M |
| Net Change in Cash | 4.6M | 21M | 4.2M | 7.7M | (9.7M) |
| Free Cash Flow | 138.4M | 61.1M | 114.9M | 132.3M | 50.8M |
ACCO Brands Corporation
NYSE:ACCO
Intrinsic Alpha fair value
Locked
Current Price
$5.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.